The protein binding of vinblastine in the serum of normal subjects and patients with Hodgkin's disease
โ Scribed by W. H. Steele; D. J. King; H. E. Barber; G. M. Hawksworth; A. A. Dawson; J. C. Petrie
- Publisher
- Springer
- Year
- 1983
- Tongue
- English
- Weight
- 400 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In 35 cases of advanced Hodgkin's disease (stage IIIB to IVB), of whom 33 were no longer responsive to the alkylating agents, vinblastine produced clinically useful remissions in 22 patients or 64%. Complete objective responses were unusual but one third of these cases experienced partial remissions
The serum protein binding of phenytoin, salicylic acid, sulfisoxazole, and warfarin was determined in normal human adults, in patients with impaired renal function (kidney donor and recipient), and in adult male Sprague--Dawley rats. The free fraction values for salicylate and sulfisoxazole were sig
## Background: In inflammatory bowel disease (ibd), enhanced inflammatory activity in the gut is thought to increase the risk of bacterial translocation and endotoxemia. in the present study we investigated the association between serum level of lipopolysaccharide-binding protein (lbp), soluble cd1